Market Overview:
The global Teglutik market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for Teglutik in emerging markets. By type, the market is segmented into film-coated and without film-coated Teglutik. Film-coated Teglutik are more popular among end users owing to their ease of use and better patient compliance as compared to without film-coated Teglutik. By application, the hospital segment dominates the global Teglutik market followed by pharmacy segment.
Product Definition:
A Teglutik is a tool used to apply plaster or stucco to a surface. It is made of metal and has a flat, triangular head that is covered in spikes. The spikes help the plaster stick to the surface better.
With Film-coated:
With film-coated tablets, the drug is released over a certain period of time and it takes effect only when it reaches the blood stream. It does not go through the gastrointestinal tract and hence there are no first pass metabolism effects. This results in increased bioavailability of drugs which means that higher amount of drug gets absorbed into the blood compared to traditional non-film coated tablets.
Without Film-coated:
Film-coated tablets are used in the treatment of hyperthyroidism and hypothyroidism. They work by blocking the action of thyroid hormones on cells, which results in reduced absorption rate and increased excretion rate of active ingredients.
Application Insights:
The hospital application segment accounted for the largest revenue share of over 70% in 2017. The rising prevalence of chronic diseases, such as cardiovascular, respiratory and diabetes disorders is expected to drive demand for the device in hospitals across the world. Furthermore, an increase in healthcare spending by governments as well as private organizations is anticipated to further fuel industry growth over the forecast period.
Pharmacy application segment is expected to witness significant growth with a CAGR of XX% from 2018 to 2030 owing to increasing awareness about health issues among consumers and growing preference for medicines due primarily only to their therapeutic benefits without any harmful effects on human body. Increasing incidences of drug-resistant bacteria are also driving market demand towards pharmacy applications worldwide.
Other applications include imaging centers, diagnostic laboratories.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising healthcare expenditure are some of the factors expected to drive regional growth over the forecast period. In addition, increasing prevalence of chronic diseases such as cancer and diabetes is anticipated to boost demand for cost-effective therapies that offer better patient outcomes at lower costs.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to untapped opportunities in this region. Rising disposable income coupled with growing awareness about advanced technologies among patients will support growth over next eight years. Moreover, expansion of insurance coverage will further fuel revenue generation through public and private partnerships between governments & health organizations; pharmaceutical companies; hospitals & clinics; etc., thereby driving regional demand for cost-effective therapeutics including Teglutik treatment options (chemotherapy drugs or radiotherapy).
Growth Factors:
- Increasing demand for Teglutik from the automotive and aerospace industries for lightweighting and corrosion resistance.
- Growing demand for Teglutik in construction and infrastructure due to its superior mechanical properties and thermal insulation properties.
- Rising demand from the electrical & electronics industry for use in high-performance applications such as LED lighting, semiconductor packaging, etc.
- Increasing adoption of Teglutik in medical devices owing to its biocompatibility characteristics.
Scope Of The Report
Report Attributes
Report Details
Report Title
Teglutik Market Research Report
By Type
With Film-coated, Without Film-coated
By Application
Hospital, Pharmacy
By Companies
Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma, Italfarmaco, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Teglutik Market Report Segments:
The global Teglutik market is segmented on the basis of:
Types
With Film-coated, Without Film-coated
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Mylan Pharma
- Apotex
- Glemark Generics
- Covis Pharma
- Sun Pharma
- Lunan Pharma
- Italfarmaco
- Sanofi
Highlights of The Teglutik Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With Film-coated
- Without Film-coated
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Teglutik Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Teglutik is a clinical-stage biotechnology company focused on the development of novel treatments for cancer. The company's lead product candidate, tegluminex (tegulizumab), is an antibody-drug conjugate that targets and inhibits the growth of tumor cells by blocking their ability to proliferate. Teglutik has completed two Phase III clinical trials in patients with advanced non-small cell lung cancer (NSCLC) and has plans to initiate a third trial in 2019.
Some of the major companies in the teglutik market are Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma, Italfarmaco, Sanofi.
The teglutik market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Teglutik Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Teglutik Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Teglutik Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Teglutik Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Teglutik Market Size & Forecast, 2018-2028
4.5.1 Teglutik Market Size and Y-o-Y Growth
4.5.2 Teglutik Market Absolute $ Opportunity
Chapter 5 Global Teglutik Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Teglutik Market Size Forecast by Type
5.2.1 With Film-coated
5.2.2 Without Film-coated
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Teglutik Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Teglutik Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Teglutik Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Teglutik Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Teglutik Analysis and Forecast
9.1 Introduction
9.2 North America Teglutik Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Teglutik Market Size Forecast by Type
9.6.1 With Film-coated
9.6.2 Without Film-coated
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Teglutik Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Teglutik Analysis and Forecast
10.1 Introduction
10.2 Europe Teglutik Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Teglutik Market Size Forecast by Type
10.6.1 With Film-coated
10.6.2 Without Film-coated
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Teglutik Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Teglutik Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Teglutik Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Teglutik Market Size Forecast by Type
11.6.1 With Film-coated
11.6.2 Without Film-coated
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Teglutik Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Teglutik Analysis and Forecast
12.1 Introduction
12.2 Latin America Teglutik Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Teglutik Market Size Forecast by Type
12.6.1 With Film-coated
12.6.2 Without Film-coated
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Teglutik Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Teglutik Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Teglutik Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Teglutik Market Size Forecast by Type
13.6.1 With Film-coated
13.6.2 Without Film-coated
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Teglutik Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Teglutik Market: Competitive Dashboard
14.2 Global Teglutik Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Mylan Pharma
14.3.3 Apotex
14.3.4 Glemark Generics
14.3.5 Covis Pharma
14.3.6 Sun Pharma
14.3.7 Lunan Pharma
14.3.8 Italfarmaco
14.3.9 Sanofi
